New Lanostane-Type Triterpenes with Anti-Inflammatory Activity from the Epidermis of .

A chemical study on the epidermis of cultivated edible mushroom resulted in the isolation and identification of 46 lanostane triterpenoids, containing 17 new compounds (-). An experimental determination of their anti-inflammatory activity showed that poricoic acid GM () most strongly inhibited NO production in LPS-induced RAW264.7 murine macrophages with an IC value at 9.73 μM. Furthermore, poricoic acid GM induced HO-1 protein expression and inhibited iNOS and COX2 protein expression as well as the release of PGE, IL-1β, IL-6, TNF-α, and reactive oxygen species (ROS) in LPS-induced RAW264.7 cells. Mechanistically, poricoic acid GM suppressed the phosphorylation of the IκBα protein, which prevented NF-κB from entering the nucleus to lose transcriptional activity and inhibited the dissociation of Keap1 from Nrf2, thereby activating Nrf2 into the nucleus to regulate antioxidant genes. Furthermore, the MAPK signaling pathway may play a significant role in poricoic acid GM-induced elimination of inflammation. This work further confirms that lanostane triterpenoids are key ingredients responsible for the anti-inflammatory properties of the edible medicinal mushroom .